In May of 2012 a group of Ukrainian pharma industry professionals and scientists created – PharmaSich, LLC.
As discovering opportunities drives most successful businesses, so PharmaSich was the fruit of endeavor to grasp opportunities that opened in front of us:
- steadily increasing number of new clinical trials in the region;
- unsatisfied needs of sponsors looking for local vendors;
- our vast first-hand experience of working within the industry.
In July, 2012 first income set the company’s “juices” flowing. In just half a year the company has won its first “large” contract from big pharma sponsor to become a sole provider for a trial with about 20 investigational sites located all over Ukraine.
In July 2015 PharmaSich acquired a Central Laboratory capable of servicing all over the country and an Investigational Medicinal Products (IMP) Depot for handling clinical trials logistics in Ukraine.
The major milestones of the company’s development are listed here:
|May 2012||PharmaSich was established by a group of pharma industry professionals and scientists.|
|Feb 2013||First project started.|
|2013-2015||PharmaSich demonstrated excellent results and efficiently supported Oncology, Infectious Diseases, Gastroenterology and Cardiovascular projects in Ukraine, Belarus and Russia.|
|Jul 2015||PharmaSich acquired a local IMP Depot in Ukraine and started providing clinical logistic services including IMP import/export, storage, distribution, destruction, and local procurement of clinical supplies.|
|Jul 2015||PharmaSich possessed dedicated Central Laboratory services.|
Today, we support multiple sponsors in their clinical projects in various therapeutic areas (Cardiovascular, Gastroenterology, Infections, Oncology) acting as a full-service CRO.
Now that our business has been fully established in Ukraine, we are expanding our operations in other Eastern European countries, Belarus, Bulgaria and Macedonia in the first instance.
PharmaSich is open to new opportunities. We are committed to building long-term relationships and ready for joint business development efforts.